Jérôme D. Coudert

5.5k total citations
42 papers, 2.1k citations indexed

About

Jérôme D. Coudert is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Jérôme D. Coudert has authored 42 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 15 papers in Epidemiology and 11 papers in Molecular Biology. Recurrent topics in Jérôme D. Coudert's work include Immune Cell Function and Interaction (22 papers), T-cell and B-cell Immunology (20 papers) and Inflammatory Myopathies and Dermatomyositis (9 papers). Jérôme D. Coudert is often cited by papers focused on Immune Cell Function and Interaction (22 papers), T-cell and B-cell Immunology (20 papers) and Inflammatory Myopathies and Dermatomyositis (9 papers). Jérôme D. Coudert collaborates with scholars based in Australia, France and Switzerland. Jérôme D. Coudert's co-authors include Werner Held, Mariapia A. Degli‐Esposti, Éric Vivier, Christopher E. Andoniou, Jean‐Charles Guéry, Léonardo Scarpellino, Iona S. Schuster, Jacques Zimmer, Mark J. Smyth and Gilles Foucras and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Immunity.

In The Last Decade

Jérôme D. Coudert

40 papers receiving 2.1k citations

Peers

Countries citing papers authored by Jérôme D. Coudert

Since Specialization

Citations

This map shows the geographic impact of Jérôme D. Coudert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme D. Coudert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme D. Coudert more than expected).

Fields of papers citing papers by Jérôme D. Coudert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme D. Coudert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme D. Coudert. The network helps show where Jérôme D. Coudert may publish in the future.

Co-authorship network of co-authors of Jérôme D. Coudert

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme D. Coudert. A scholar is included among the top collaborators of Jérôme D. Coudert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme D. Coudert. Jérôme D. Coudert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Expression and Site-Specific Biotinylation of Human Cytosolic 5′-Nucleotidase 1A in Escherichia coli 2025 ·Methods and Protocols ·(unknown), (unknown), Frank Mastaglia, Sue Fletcher, Mark Watson, Merrilee Needham, Jérôme D. Coudert	0
2	Identification of distinct immune signatures in inclusion body myositis by peripheral blood immunophenotyping using machine learning models 2024 ·Clinical & Translational Immunology ·(unknown), (unknown), (unknown), (unknown), Ian Cooper, Frank Mastaglia, Merrilee Needham, Jérôme D. Coudert	4
3	Testosterone treatment combined with exercise to improve muscle strength, physical function and quality of life in men affected by inclusion body myositis: A randomised, double-blind, placebo-controlled, crossover trial 2023 ·PLoS ONE ·(unknown), Timothy J. Fairchild, Yvonne C. Learmonth, (unknown), Ian Cooper, (unknown), Shaun Y. M. Teo, (unknown), Rui Zhang, (unknown), Jérôme D. Coudert, Bu B. Yeap, Merrilee Needham	11
4	Uncovering the significance of expanded CD8+ large granular lymphocytes in inclusion body myositis: Insights into T cell phenotype and functional alterations, and disease severity 2023 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Phillipa J. Lamont, Abha Chopra, Frank Mastaglia, Merrilee Needham, Jérôme D. Coudert	7
5	High-resolution HLA genotyping in inclusion body myositis refines 8.1 ancestral haplotype association to DRB103:01:01 and highlights pathogenic role of arginine-74 of DRβ1 chain 2023 ·Journal of Autoimmunity* ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Christine Bundell, Ian James, Abha Chopra, Frank Mastaglia, Merrilee Needham, Jérôme D. Coudert	10
6	Manipulating the NKG2D Receptor-Ligand Axis Using CRISPR: Novel Technologies for Improved Host Immunity 2021 ·Frontiers in Immunology ·(unknown), (unknown), Pilar Blancafort, Jérôme D. Coudert, Silvana Gaudieri	6
7	A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment 2017 ·Cancer Research ·Arabella Young, Shin Foong Ngiow, (unknown), Ann‐Marie Patch, Deborah S. Barkauskas, Meriem Messaoudene, Gene Lin, Jérôme D. Coudert, Kimberley Stannard, Laurence Zitvogel, Mariapia A. Degli‐Esposti, Éric Vivier, Nicola Waddell, Joel Linden, Nicholas D. Huntington, Fernando Souza-Fonseca-Guimarães, Mark J. Smyth	296
8	“Natural Regulators”: NK Cells as Modulators of T Cell Immunity 2016 ·Frontiers in Immunology ·Iona S. Schuster, Jérôme D. Coudert, Christopher E. Andoniou, Mariapia A. Degli‐Esposti	110
9	A Natural Genetic Variant of Granzyme B Confers Lethality to a Common Viral Infection 2014 ·PLoS Pathogens ·Christopher E. Andoniou, Vivien R. Sutton, Matthew E. Wikström, Peter Fleming, Kevin Thia, Antony Y. Matthews, Dion Kaiserman, Iona S. Schuster, Jérôme D. Coudert, Preethi Eldi, Geeta Chaudhri, Gunasegaran Karupiah, Phillip I. Bird, Joseph A. Trapani, Mariapia A. Degli‐Esposti	24
10	TRAIL+ NK Cells Control CD4+ T Cell Responses during Chronic Viral Infection to Limit Autoimmunity 2014 ·Immunity ·Iona S. Schuster, Matthew E. Wikström, Géraldine Brizard, Jérôme D. Coudert, Marie J. Estcourt, Mitali Manzur, Lorraine A. O’Reilly, Mark J. Smyth, Joseph A. Trapani, Geoffrey R. Hill, Christopher E. Andoniou, Mariapia A. Degli‐Esposti	142
11	Ly49C-Dependent Control of MCMV Infection by NK Cells Is Cis-Regulated by MHC Class I Molecules 2014 ·PLoS Pathogens ·Catherine A. Forbes, Anthony A. Scalzo, Mariapia A. Degli‐Esposti, Jérôme D. Coudert	23
12	Targeting of a natural killer cell receptor family by a viral immunoevasin 2013 ·Nature Immunology ·Richard Berry, (unknown), Philippa M. Saunders, J.P. Vivian, Jie Lin, (unknown), Alexandra J. Corbett, Catherine A. Forbes, Jacqueline Widjaja, Lucy C. Sullivan, (unknown), Matthew A. Perugini, Melissa Call, Anthony A. Scalzo, Mariapia A. Degli‐Esposti, Jérôme D. Coudert, Travis Beddoe, Andrëw G. Brööks, Jamie Rossjohn	37
13	Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells 2008 ·Blood ·Sophie Laffont, Cyril Seillet, John R. Ortaldo, Jérôme D. Coudert, Jean‐Charles Guéry	83
14	Killers and beyond: NK‐cell‐mediated control of immune responses 2008 ·European Journal of Immunology ·Christopher E. Andoniou, Jérôme D. Coudert, Mariapia A. Degli‐Esposti	63
15	Interactions of Ly49 Family Receptors with MHC Class I Ligands in trans and cis 2007 ·The Journal of Immunology ·Léonardo Scarpellino, Franziska M. Oeschger, Philippe Guillaume, Jérôme D. Coudert, Frédéric Lévy, Georges Leclercq, Werner Held	70
16	The role of the NKG2D receptor for tumor immunity 2006 ·Seminars in Cancer Biology ·Jérôme D. Coudert, Werner Held	103
17	Effect of Hypervolemia on Heart Rate During 4 Days of Prolonged Exercises 2003 ·International Journal of Sports Medicine ·Rémi Mounier, Vincent Pialoux, (unknown), Jérôme D. Coudert, (unknown)	9
18	The NK cell receptor repertoire: formation, adaptation and exploitation 2003 ·Current Opinion in Immunology ·Werner Held, Jérôme D. Coudert, Jacques Zimmer	25
19	Preventing NK Cell Activation by Donor Dendritic Cells Enhances Allospecific CD4 T Cell Priming and Promotes Th Type 2 Responses to Transplantation Antigens 2002 ·The Journal of Immunology ·Jérôme D. Coudert, Christiane Coureau, Jean‐Charles Guéry	37
20	Dendritic Cells Prime In Vivo Alloreactive CD4 T Lymphocytes Toward Type 2 Cytokine- and TGF-β-Producing Cells in the Absence of CD8 T Cell Activation 2000 ·The Journal of Immunology ·Gilles Foucras, Jérôme D. Coudert, Christiane Coureau, Jean‐Charles Guéry	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact